Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘31 January 2027’;
in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘30 September 2026’;
in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 May 2026’;
in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘31 October 2026’;
in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘31 January 2027’;
in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘31 October 2026’;
in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘31 October 2026’;
in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘31 October 2026’;
in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 June 2026’;
in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘31 October 2026’;
in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘30 September 2026’;
in the sixth column, expiration of approval, of row 204, Trichoderma atroviride (formerly T. harzianum) strain T11, the date is replaced by ‘30 November 2026’;
in the sixth column, expiration of approval, of row 206, Trichoderma harzianum Rifai strains T-22 and ITEM 908, the date is replaced by ‘30 November 2026’;
in the sixth column, expiration of approval, of row 207, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T-25 and TV-1, the date is replaced by ‘30 November 2026’;
in the sixth column, expiration of approval, of row 208, Trichoderma gamsii (formerly T. viride) strain ICC080, the date is replaced by ‘30 November 2026’;
in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 July 2026’.
Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 35, Halosulfuron-methyl, the date is replaced by ‘15 November 2026’;
in the sixth column, expiration of approval, of row 50, Pseudomonas sp. strain DSMZ 13134, the date is replaced by ‘30 June 2027’;
in the sixth column, expiration of approval, of row 52, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), the date is replaced by ‘30 June 2027’;
in the sixth column, expiration of approval, of row 53, Pyriofenone, the date is replaced by ‘30 June 2027’;
in the sixth column, expiration of approval, of row 58, Benalaxyl-M, the date is replaced by ‘30 September 2027’;
in the sixth column, expiration of approval, of row 61, Pyroxsulam, the date is replaced by ‘30 September 2027’;
in the sixth column, expiration of approval, of row 83, Bacillus amyloliquefaciens subsp. plantarum D747, the date is replaced by ‘31 August 2027’.
In Part E of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, expiration of approval, of row 8, Imazamox, the date is replaced by ‘30 June 2027’.